BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

former CEO of Henry Schein's Global Dental Group, and A.J. Caffentzis, former president of its U.S. dental division. The departures raised concerns that top executives who might have been ...

Health care product distributor Henry Schein has redoubled its effort to ... to proactively supply vulnerable areas with medical and dental supplies—so supplies are there even if roads or ...

Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to improve its operations, the Wall Street Journal reported on Wednesday ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of Henry Schein ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...